ReviewFrontiers in neuroscience2021
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.
Eiko N Minakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it